Oosthuizen Johannes Jacobus 4
4 · Merck & Co., Inc. · Filed May 6, 2024
Insider Transaction Report
Form 4
Oosthuizen Johannes Jacobus
EVP, Oncology & Int?l
Transactions
- Exercise/Conversion
Common Stock
2024-05-04$127.51/sh+912$116,289→ 24,270.949 total - Tax Payment
Common Stock
[F1]2024-05-04$127.51/sh−450$57,380→ 23,820.949 total - Exercise/Conversion
Restricted Stock Unit
[F2][F3]2024-05-04−912→ 0 totalFrom: 2022-05-04Exp: 2024-05-04→ Common Stock (912 underlying)
Footnotes (3)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F3]These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
Signature
/s/ Kelly E. W. Grez, as attorney-in-fact for Johannes Oosthuizen|2024-05-06